Close up overjoyed young mother and daughter hugging and laughing
49 items
29h17m
EN
Ketogenic diet therapy is not a uniform intervention. Its application, tolerability, and efficacy profile vary across pediatric epilepsy syndromes including infantile spasms, Dravet syndrome, and Angelman syndrome, each presenting distinct clinical challenges that influence dietary management decisions.
Expert clinical perspectives from international ketogenic diet specialists examine how KDT performs across these complex presentations, where it delivers meaningful seizure reduction, and what clinical considerations guide implementation across diverse syndrome profiles. This collection bridges the gap between guideline recommendations and real-world specialist practice.
Happy, hug and face of a doctor with a woman for medical trust, healthcare and help. Laughing, care and portrait of a young nurse with a senior patient and love during a consultation at a clinic
family doctor pediatrician conducts examination of child boy and giving high five to him
Drug-resistant epilepsy is defined by failure to achieve sustained seizure control following adequate trials of two or more tolerated anti-seizure medications. In pediatric populations, uncontrolled seizures carry compounding consequences including long-term cognitive decline, impaired psychomotor development, and significant family burden.
For patients where surgery and neurostimulation are not appropriate, ketogenic diet therapy provides a clinically validated pathway. International guidelines recommend its consideration after failure of two to three drugs, with demonstrated efficacy across syndromes including infantile spasms, Dravet syndrome, and Angelman syndrome.
Up to 28% of children with drug-resistant epilepsy achieve seizure freedom on ketogenic diet therapy, while up to 60% experience a greater than 50% reduction in seizure frequency. Beyond seizure control, documented benefits include improvements in sleep quality, cognitive function, and behaviour, outcomes that carry significant weight in long-term pediatric care planning.
These findings, presented alongside guideline-recommended thresholds for initiating KDT, provide the evidence base needed to support referral decisions, family discussions, and formulary considerations for dietary intervention in this population.
Doctor, women and tablet for happy healthcare, hospital news and support with test results or exam on bed. Senior nurse and patient with digital registration, clinic sign up and medical consultation
Related Content
- Items
- Collections
Current Views In Pediatric Nutrition: Vol.2, No.1, 2023
Current Views In Pediatric Nutrition: Vol.2, No.2, 2023
Current Views In Pediatric Nutrition: Vol.1, No.3, 2019
The Broad Spectrum Of Ketogenic Diet Therapy _ Neuroinflammation
How To Set Up A Ketogenic Diet Team
Ketogenic Diet Therapy An Established Therapy For Adults With Drug Resistant Epilepsy
webinar
40m
en
Not completed
KDT at 103 years Past, Present, and Future
Managing Drug-Resistant Epilepsy with Ketogenic Diet Therapy
KETOGENIC DIETARY THERAPY (KDT) FOR THE TREATMENT OF EPILEPSY
Early KDT in infancy - chances and new challenges?
Dietary treatment of adult: drug resistant epilepsy
missOrigin
spotlight-biotics
spotlight-c-section
11 items
en
2x
1x
1x
1x
1x
5x
Not completed
PPPP 2026
3 items
en
Not completed